# Nevakar: Biopharma, Bridgewater, United States

> Nevakar: Nevakar is a specialty pharmaceutical company that focuses on the development of innovative products in the injectable and ophthalmic space.

Source: https://millionrounds.com/startup/nevakar (Millionrounds; every figure on the page links to its filing or article)

United States · [Biopharma startup](https://millionrounds.com/companies)

# Nevakar

Nevakar is a specialty pharmaceutical company that focuses on the development of innovative products in the injectable and ophthalmic space.

Email

Funding reported Last round: Private equity

Biopharma Bridgewater, United States

Follow Nevakar and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fnevakar)

Company summary

- **Founded:** 2015 11 years old
- **Team:** 11 11 to 50 people
- **Funding reported:** $135M in dollars
- **Last round:** Private equity Jun 2019

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Nevakar has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Nevakar raised

Funding, as reported

Reported in all **$135M** in dollars

Rounds **3**

Last round **Private equity**

Last round date **Jun 2019**

Investors listed **3**

SEC Form D **$16M sold, 2 filings, last Aug 2023**

## Founders and team

From the SEC filings it signed: 3 on the team.

- **Navneet Puri** Executive Officer, Director i
- **Raul Trillo** Executive Officer, Director i
- **Sri Ramanathan** Executive Officer i

On the board, as filed i *Alex Sisson* *George Zorich* *Ram Potti* *Ron Wooten*

## On a portfolio page

Investors who name them

- [NovaQuest](https://millionrounds.com/fund/novaquest-capital-management)

Each firm lists Nevakar on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biopharma in United States

Startups like it

- [**Altos Labs** San Francisco · founded 2021](https://millionrounds.com/startup/altos-labs)
- [**Vaxcyte** San Carlos · founded 2013](https://millionrounds.com/startup/vaxcyte)
- [**Madrigal Pharmaceuticals** Conshohocken · founded 2011](https://millionrounds.com/startup/madrigal-pharmaceuticals)
- [**Harmony Biosciences** Plymouth Meeting · founded 2017](https://millionrounds.com/startup/harmony-biosciences)
- [**Kura Oncology** La Jolla · founded 2014](https://millionrounds.com/startup/kura-oncology)
- [**Immunovant** New York · founded 2018](https://millionrounds.com/startup/immunovant)
- [**Solugen** Houston · founded 2016](https://millionrounds.com/startup/solugen-2)
- [**Dianthus Therapeutics** Waltham · founded 2019](https://millionrounds.com/startup/dianthus-therapeutics)

## Is this your company?

Add your raise, your deck and your story, and put Nevakar in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)